Navigation Links
Sanofi-aventis Announces Non-Binding Offer to Acquire Genzyme
Date:8/29/2010

treatments, enhance penetration in existing markets and expand further into emerging markets. The combination of both companies would create a global leader in developing and providing novel treatments, giving both companies significant new growth opportunities.

"A combination with Genzyme represents a compelling opportunity for both companies and our respective shareholders and is consistent with our sustainable growth strategy," said Christopher A. Viehbacher, Chief Executive Officer of sanofi-aventis. "Sanofi-aventis shares Genzyme's commitment to improving the lives of patients, and our global reach and resources can help the company better navigate the issues it faces today.  The all-cash offer provides immediate and certain value for Genzyme shareholders at a substantial premium that recognizes the company's upside potential, while sanofi-aventis shareholders would benefit from the accretion and the attractive growth prospects of this combination. Now is the right time for Genzyme to consider a transaction that maximizes value for its shareholders. Sanofi-aventis believes strongly in this acquisition and its strategic and financial benefits. We remain focused on entering into constructive discussions with Genzyme in order to complete this transaction."

Sanofi-aventis has a strong track record of successfully acquiring and integrating a diverse range of businesses and has consistently demonstrated its commitment to allow affiliates to focus on their core competencies. Sanofi-aventis intends to make Genzyme its global center for excellence in rare diseases and further increase sanofi-aventis's presence in the greater Boston area.

At this stage, there can be no assurance that any agreement could be reached between the two companies. Sanofi-aventis is prepared to consider all alternatives to successfully complete this transaction.

Conference Call Sanofi-aventis will hold a call for investors and analysts on
'/>"/>

SOURCE Sanofi-aventis
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Sanofi-Aventis and Novalar File Marketing Authorization Application for OraVerse® in Five Key European Countries
2. Oramed Pharmaceuticals and sanofi-aventis Enter Into an Agreement for the Insulin Supply of Orameds Oral Insulin Capsules
3. Sanofi-aventis Successfully Completes The Acquisition of Chattem, Inc.
4. Sanofi-aventis Successfully Completes Tender Offer for Chattem, Inc.
5. Sanofi-aventis Obtains Antitrust Clearance in Connection With Chattem, Inc. Tender Offer
6. Sanofi-aventis Commences Tender Offer for All Outstanding Shares of Chattem, Inc.
7. Sanofi-aventis to Acquire Chattem Inc., Creating a Strong U.S. Consumer Healthcare Platform
8. Intelliject, Inc. Enters Into Licensing Agreement with sanofi-aventis for U.S./Canada Rights to Novel Epinephrine Auto-injector
9. Sanofi-aventis U.S. and Intelliject, Inc. Sign Licensing Agreement for Novel Epinephrine Auto Injector in North America
10. Sanofi-aventis: Multaq(R) Approved in the European Union for Patients With Atrial Fibrillation
11. Sanofi-aventis and Regeneron Expand Strategic Antibody Collaboration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... Over-the-counter healthcare costs can be a ... new survey of store brand over-the-counter products aimed ... to diabetes, can offer significant savings for those ... Private Label Manufacturers Association, assembled a market basket ... essential for treatment of pre-diabetes and diabetes. These ...
(Date:3/26/2015)... 2015  Desert Valley Medical Center, named a Top ... is the first U.S. hospital to deploy the wireless ... help clinicians prevent hospital acquired pressure ulcers. ... , is a community hospital serving some higher risk ... Patient Monitor in the hospital,s emergency department enables the ...
(Date:3/26/2015)... Californie, 26 mars 2015 Finesse Solutions ... conçu pour les innovateurs, visionnaires et cadres de ... conférence d,une durée de deux jours proposée exclusivement ... dans le centre ville de San ... 2015. Il s,agira d,un forum destiné aux leaders ...
Breaking Medicine Technology:Consumers can keep over-the-counter medicine affordable by using store brands 2Desert Valley Medical Center First to Use Leaf Healthcare Patient Wearable Technology in its ED as Part of Hospital-wide Deployment 2Desert Valley Medical Center First to Use Leaf Healthcare Patient Wearable Technology in its ED as Part of Hospital-wide Deployment 3Finesse Solutions annonce l'événement Cellworld 2015 2
... Its USD520.6 million Sale to Sanofi-... -- PARIS, Nov. 1, 2010 /PRNewswire-Asia/ -- ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... BitlyCB.alertResponse = function(data) { var s = ,; var first_result; // Results are keyed by longUrl, so we need ...
... NeoStem, Inc. (NYSE Amex: NBS ) ... operations in the U.S. and China, today announced that ... (China), Inc., the Company,s wholly-owned subsidiary, will present "Building ... Therapy Industry Summit 2010 hosted by Life Technologies Corporation ...
Cached Medicine Technology:E. J. McKay Advises BMP Sunstone on Its USD520.6 million Sale to Sanofi- aventis 2E. J. McKay Advises BMP Sunstone on Its USD520.6 million Sale to Sanofi- aventis 3E. J. McKay Advises BMP Sunstone on Its USD520.6 million Sale to Sanofi- aventis 4E. J. McKay Advises BMP Sunstone on Its USD520.6 million Sale to Sanofi- aventis 5E. J. McKay Advises BMP Sunstone on Its USD520.6 million Sale to Sanofi- aventis 6E. J. McKay Advises BMP Sunstone on Its USD520.6 million Sale to Sanofi- aventis 7E. J. McKay Advises BMP Sunstone on Its USD520.6 million Sale to Sanofi- aventis 8NeoStem to Present at Cell Therapy Industry Summit to be held on November 3-5, 2010 in Carlsbad, California 2NeoStem to Present at Cell Therapy Industry Summit to be held on November 3-5, 2010 in Carlsbad, California 3
(Date:3/26/2015)... “The SWEET Act is an important step ... available and help parents who are working to reduce sugar ... approach to support public health, and we will continue to ... health of all families,” said Dr. Jane Delgado President and ... introduction of the Sugar-Sweetened Beverage Tax (SWEET) Act by Congresswoman ...
(Date:3/26/2015)... Dr. Alex Rabinovich and his San Francisco ... for Bay Area patients considering dental implants or teeth ... been a top-rated center, serving primarily San Franciscans; however, ... strong demand by others throughout Northern California. , “We ... implant facility in San Francisco,”explained Dr. Alex Rabinovich, owner ...
(Date:3/26/2015)... Springs, FL (PRWEB) March 26, 2015 ... of the nation’s leading innovative specialty pharmacies, announces ... created position of Vice President of Pharmaceutical Relations. ... fostering beneficial connections with our pharmaceuticals partners and ... relationships in support of BioPlus’ expansion. , ...
(Date:3/26/2015)... UK (PRWEB) March 26, 2015 In the ... billion as of 2013 and is set to decrease through ... by 2020; the growth is expected up to 2017 at ... is expected to be owing to the surging penetration of ... HCT, Twynsta, Micardis Plus, Valturna, Benicar HCT, and Tekamlo), a ...
(Date:3/26/2015)... Sunrise, FL (PRWEB) March 26, 2015 ... unveiled its brand-new, state-of-the-art company website: http://www.metabolicnutrition.com ... of the revamped website creates a user-friendly experience ... supplement company. , The new, enhanced Metabolic ... Comprehensive information about the company’s diverse line of ...
Breaking Medicine News(10 mins):Health News:National Alliance for Hispanic Health Statement on Introduction of SWEET Act in 114th Congress 2Health News:Bay Area Dental Implant Specialist, Dr. Alex Rabinovich Announces Regional Educational Strategy 2Health News:Bay Area Dental Implant Specialist, Dr. Alex Rabinovich Announces Regional Educational Strategy 3Health News:BioPlus Specialty Pharmacy Expands Executive Team with New Position, Naming Sharon Ferrer as Vice President of Pharmaceutical Relations 2Health News:Top 8 Developed Anti-Hypertensive Therapeutics Markets Discussed in New GBI Research Report Published at MarketPublishers.com 2Health News:Top 8 Developed Anti-Hypertensive Therapeutics Markets Discussed in New GBI Research Report Published at MarketPublishers.com 3Health News:Metabolic Nutrition Launches Sleek New Website with New Features and Enhanced Consumer Information 2
... use of alternative or complementary therapies have increased over ... using // at least one form of alternative medicine. ... yoga, hypnosis, acupuncture, chiropractic care, and high-dose vitamins. ... own survey taken in 1997 to the National Health ...
... disorder, where white blood cells attack fatty tissue surrounding nerve ... is twice as common in women as in men . ... with multiple sclerosis. Since MS causes muscle weakness and fatigue, ... of life, researchers designed an exercise program to develop ...
... days of physical inactivity, the body's efficient use of insulin ... ,Researchers conducted a study in rats and found insulin sensitivity ... stopped running for two days after a period of running ... muscle in response to insulin was found to have decreased ...
... Duchenne muscular dystrophy (DMD) with the oral steroid prednisone is ... effects of the drug . Most patients with this form ... 20s from respiratory failure or heart problems. Despite the beneficial ... side effects, which can range from weight gain to behavioral ...
... people who carry a gene that produces a higher ... increased risk for stroke.// ,Researchers reviewed medical literature ... that previous study results were observational in nature. A ... factors by looking at data on the link between ...
... coronary heart disease who follow a heart-healthy diet and ... // medications that raise HDL (high-density lipoproteins or "good" ... studied 143 patients younger than 76 with low HDL ... study followed a heart-healthy diet and lost weight. However, ...
Cached Medicine News:
... Sun Med TruFlow™ Oxygen flowmeter with ... lifetime warranty covering calibration and manufacturing defects. ... to meet most needs. Also available with ... auxiliary power take-off and double unit configurations. ...
... TruFlow™ Oxygen flowmeter with a Lexan®inner calibrated ... calibration and manufacturing defects. A wide range ... needs. Also available with all popular inlet ... and double unit configurations. Our extra large ...
... Oxygen flowmeter with a Lexan®inner calibrated flow ... and manufacturing defects. A wide range of ... Also available with all popular inlet connections, ... double unit configurations. Our extra large knob ...
... Sun Med TruFlow™ Oxygen flowmeter with ... lifetime warranty covering calibration and manufacturing defects. ... to meet most needs. Also available with ... auxiliary power take-off and double unit configurations. ...
Medicine Products: